Nihon Kohden Corporation
Stock Price Chart
2026/03/05 UpdatedPrice Trend
2026/03/05 UpdatedPrice & Trading Details
2026/03/05 UpdatedPRICE
TRADING
Analyst Recommendations 7 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Major Holders
Updated 2026/03/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
First Eagle Funds-First Eagle Overseas Fund
|
6.2M | +7.47% | |
|
VANGUARD TRUSTEES' EQUITY FUND-Vanguard International Value Fund
|
3.4M | -3.70% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.3M | +1.72% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.5M | +4.81% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.1M | 0.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
578.1K | +1.74% |
Dividend History 1Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥32 | +4.9% |
| 2024 | ¥31 | -14.1% |
| 2023 | ¥36 | +4.4% |
| 2022 | ¥34 | +19.3% |
| 2021 | ¥29 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥205,129M | ¥206,603M | ¥221,986M | ¥225,424M |
| Gross Profit | ¥109,085M | ¥105,926M | ¥111,346M | ¥117,157M |
| Operating Income | ¥30,992M | ¥21,121M | ¥19,591M | ¥20,713M |
| Pretax Income | ¥34,274M | ¥24,726M | ¥29,393M | ¥21,714M |
| Net Income | ¥23,435M | ¥17,110M | ¥17,026M | ¥14,098M |
| EPS | ¥138.25 | ¥101.64 | ¥101.22 | - |
| Operating Margin | 15.11% | 10.22% | 8.83% | 9.19% |
| Balance Sheet | ||||
| Total Assets | ¥210,201M | ¥216,728M | ¥233,233M | ¥258,276M |
| Total Equity | ¥156,378M | ¥167,602M | ¥181,080M | ¥179,550M |
| Total Liabilities | ¥53,823M | ¥49,126M | ¥52,153M | ¥78,726M |
| Cash | ¥28,925M | ¥33,459M | ¥36,132M | ¥28,428M |
| Interest-bearing Debt | ¥359M | ¥441M | ¥654M | ¥26,076M |
| Equity Ratio | 74.39% | 77.33% | 77.64% | 69.52% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.15 |
| Cash Flow | ||||
| Operating CF | ¥25,699M | -¥2,513M | ¥15,607M | ¥15,286M |
| Investing CF | -¥4,303M | -¥7,647M | -¥5,208M | -¥25,138M |
| Financing CF | -¥7,300M | -¥7,485M | -¥6,968M | ¥2,550M |
| Free CF | ¥22,765M | -¥10,769M | ¥10,821M | ¥6,577M |
| Efficiency | ||||
| ROE | 14.99% | 10.21% | 9.40% | 7.85% |
| ROA | 11.15% | 7.89% | 7.30% | 5.46% |
Latest IR Information
-
Notice Regarding Recruitment Results of the "Career Change Support Program" and "Next Career Support Program"
152 applicants for the career change support programs, special loss of 2.4 billion yen recorded for early retirement benefits and others. SG&A expenses are expected to decrease by 1.8 billion yen in the fiscal year ending March 2027.
Read more -
Notice Regarding the Status of Share Buyback (Share Buyback Based on the Provision of Article 165, Paragraph 2 of the Companies Act)
Acquired 1,052,800 shares of treasury stock totaling JPY 1,792,151,600 from February 1 to February 28, 2026. The cumulative number of shares acquired is 1,771,000 shares with a total amount of JPY 2,899,975,100.
Read more -
Notice Regarding Revision of Earnings Guidance
Revised consolidated earnings guidance for the fiscal year ending March 2026 to net sales of 235 billion yen (2.1% decrease from previous forecast), operating income of 20 billion yen (16.7% decrease). Net income is maintained at 12.5 billion yen.
Read more -
(Disclosure Progress) Notice Regarding Partial Changes and Recruitment Status of the "Career Transition Support Program" and "Next Career Support Program"
The recruitment period for the career transition support program and the retirement date were extended, with 147 applicants as of the end of December 2025. Early retirement premium costs of 2.4 billion yen were recorded as an extraordinary loss and...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥2,104
Rating Score: 2.43 (Based on 7 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers Defibrillators, AEDs, ventilators, pacemakers, anesthesia machines, cochlear implants, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
